89bio CEO Rohan Palekar buys 83,500 in company stock

ETNB Stock  USD 7.94  0.91  12.94%   
About 64% of all 89bio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding 89bio Inc suggests that some traders are interested. The current market sentiment, together with 89bio's historical and current headlines, can help investors time the market. In addition, many technical investors use 89bio Inc stock news signals to limit their universe of possible portfolio assets.
  
89bio CEO Rohan Palekar buys 83,500 in company stock

Read at investing.com
Investing News at Macroaxis
  

89bio Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards 89bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

89bio Fundamental Analysis

We analyze 89bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 89bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 89bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

89bio is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

89bio Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 89bio stock to make a market-neutral strategy. Peer analysis of 89bio could also be used in its relative valuation, which is a method of valuing 89bio by comparing valuation metrics with similar companies.

Peers

89bio Related Equities

INZYInozyme Pharma   6.41   
0%
84.0%
MDGLMadrigal Pharmaceuticals   5.12   
0%
67.0%
TGTXTG Therapeutics   4.04   
0%
53.0%
STOKStoke Therapeutics   3.36   
0%
44.0%
AKROAkero Therapeutics   3.31   
0%
43.0%
ABOSAcumen Pharmaceuticals   2.78   
0%
36.0%
DAWNDay One   2.65   
0%
35.0%
VKTXViking Therapeutics   1.83   
0%
24.0%
MREOMereo BioPharma   1.82   
0%
24.0%
ACLXArcellx   0.44   
0%
5.0%
PLRXPliant Therapeutics   0.68   
9.0%
0%
TERNTerns Pharmaceuticals   3.14   
41.0%
0%
XFORX4 Pharmaceuticals   4.69   
62.0%
0%
HOOKHookipa Pharma   5.61   
74.0%
0%
HEPAHepion Pharmaceuticals   7.55   
100.0%
0%

Complementary Tools for 89bio Stock analysis

When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital